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The neisserial opacity (Opa) proteins are a family of antigenically distinct outer membrane proteins that
undergo phase-variable expression. Opa variants of Neisseria gonorrhoeae strain FA1090 are selected in a
cyclical pattern from the lower genital tract of estradiol-treated mice. Here we show that cyclical recovery of
Opa gonococci does not occur in ovariectomized mice; therefore, the reproductive cycle plays a role in the
selection kinetics in vivo. As predicted by the selection pattern shown by wild-type gonococci, we demonstrated
that a constitutive Opa-expressing strain was more fit than an Opa-deficient mutant in the early and late
phases of infection. We found no evidence that Opa-mediated colonization selects for Opa variants during
murine infection based on adherence assays with cultured murine epithelial cells. We also tested the hypothesis
that complement selects for Opa protein expression during infection. Although some Opa variants of a
serum-sensitive derivative of strain FA1090 were more resistant to the bactericidal activity of normal human
serum, selection for Opa expression was not abrogated in C3-depleted mice. Finally, as previously reported,
Opa gonococci were more sensitive to serine proteases. Thus, proteases or protease inhibitors may contribute
to the observed in vivo selection pattern. We concluded that Opa proteins promote persistence of N. gonorrhoeae
in the female genital tract and that opa gene phase variation allows gonococci to evade or capitalize upon
unidentified host factors of the mammalian reproductive cycle. This work revealed an intimate interaction
between pathogen and host and provides evidence that hormonally related factors shape bacterial adaptation.
Neisseria gonorrhoeae is a Gram-negative pathogen that most
commonly colonizes the urethra, cervix, pharynx, and rectum
of infected individuals. The gonococcus frequently ascends to
the upper reproductive tract of females, and ascension to the
epididymis can also occur in males. Hematogenous dissemina-
tion to the skin and joints can occur in both genders (25, 26).
The gonococcus has no reservoir outside humans and there-
fore has evolved many sophisticated mechanisms for ensuring
its survival within humans, including variable expression of
surface molecules via high-frequency, reversible frameshift
mutations. This trait provides a mechanism for evading a spe-
cific immune response, as well as flexibility in colonizing dif-
ferent niches within the host due to functional differences
among variant phenotypes. The neisserial opacity (Opa) pro-
teins are a well-studied example of phase-variable surface
structures. Gonococcal strains express 8 to 10 antigenically
distinct Opa proteins that are encoded by separate chromo-
somal alleles (2, 11, 14). Each opa gene independently under-
goes phase variation at a rate of 103/cell/generation (37) via
frameshift mutations that cause changes in the number of
pentameric repeats in the opa structural gene (39). Bacteria
that express no Opa proteins, bacteria that express one Opa
protein, and bacteria that express multiple Opa proteins simul-
taneously result from these reversible mutations.
The maintenance of 11 or 12 opa alleles by the gonococcus
suggests that Opa proteins provide an advantage during infec-
tion. The best-characterized function for Opa proteins is adher-
ence to and invasion of host cells via binding to members of the
human carcinoembryonic antigen-related cellular adhesion mol-
ecule (CEACAM) family, namely, CEACAM1, CEACAM3,
CEA, and CEACAM6. Some Opa proteins also mediate uptake
through binding to heparin sulfate proteoglycans (HSPGs) (for
reviews, see references 13 and 40]. Opa proteins may also mediate
evasion of host defenses; recent in vitro studies suggested an
immunosuppressive role for the CEACAM1-Opa interaction on
lymphocytes (7, 44) and epithelial cells (54), and Bos et al. (5)
showed that Opa protein expression causes increased resis-
tance to complement-mediated bacteriolysis. The hypothesis
that Opa proteins are important during infection is further
supported by the demonstration that mostly Opa variants are
recovered from the urethras of experimentally (29, 50, 58) and
naturally (27) infected men. Opa expression also occurs in the
female genital tract, although the recovery of different Opa
phenotypes appears to be influenced by the hormonal state and
anatomical site. In an analysis of 104 cervical isolates, predom-
inantly opaque (Opa) colonies were isolated from women
prior to ovulation (high estrogen), while mostly transparent
colonies were isolated prior to or during menses (27). Addi-
tionally, in one study Opa variants were isolated from the
fallopian tubes, regardless of the stage of the menstrual cycle
(15).
Based on the analysis of gonococcal isolates from women, it
has been hypothesized that certain Opa phenotypes are better
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adapted for different stages of the reproductive cycle (27). This
hypothesis is supported by clinical evidence indicating that the
gonococcus has evolved mechanisms for adapting to hormon-
ally driven changes in the female genital tract. For example,
there have been several reports that gonococci are either re-
duced in number or less accessible to cervical culture during
the secretory stage of the menstrual cycle (high progesterone,
low estrogen) (27, 32 35, 38), and the correlation between the
onset of gonococcal pelvic inflammatory disease and menses is
well established (1, 19). The factors responsible for the ob-
served associations between Opa phenotype, culture rate, and
the menstrual cycle are not known. Salit (49) showed that
opaque colonies were more resistant to progesterone than
transparent colonies; however, the resultant hypothesis that
Opa proteins directly protect gonococci from progesterone was
not supported when gonococci with defined Opa phenotypes
were tested (52). It is possible that the expression of Opa
protein colonization receptors is hormonally regulated. Fluc-
tuations in complement and proteases over the course of the
reproductive cycle could also select for Opa variants in vivo
based on evidence that Opa proteins confer increased resis-
tance to complement-mediated bacteriolysis (5) and serine
proteases (27, 57).
The role of host factors in the recovery of certain Opa
phenotypes has not been tested in a female infection model.
Currently, the only female animal model of gonococcal genital
tract infection is experimental infection of BALB/c mice that
are treated with 17-estradiol to promote an estrus-like state.
While the capacity of female mice to reproduce human infec-
tion is limited due to several host restrictions, including the
absence of human CEACAMS, several other aspects of human
infection are mimicked by murine infection. Gonococci are
associated with vaginal cells in infected mice (28) and are
localized within vaginal and cervical tissue, including the lam-
ina propria (56). Infected mice develop an inflammatory re-
sponse that is characterized by an influx of neutrophils and the
production of proinflammatory cytokines and chemokines
(43). Also consistent with human infection, mice develop an
unremarkable and transient antibody response to N. gonor-
rhoeae and are susceptible to reinfection with the same strain
(56). Additionally, the in vivo phenotype of several defined
gonococcal mutants when tested in mice was the phenotype
predicted from studies with human neutrophils and antimicro-
bial peptides (55, 63–65). The recovery of Opa variants during
infection of female mice is also similar to the selection dynam-
ics that is predicted from analysis of human cervical isolates.
Selection of subpopulations of Opa gonococci occurs early
during infection of estradiol-treated female mice, and interest-
ingly, the recovery of Opa variants over time is cyclical. Con-
sistent with the hypothesis that Opa and Opa populations of
bacteria have distinct advantages in vivo, shifts in the predom-
inant Opa phenotype of vaginal isolates are paralleled by fluc-
tuations in the total number of gonococci recovered (52).
Here we tested the hypothesis that the cyclical recovery
pattern is independent of estradiol administration and is due to
endogenous factors related to the reproductive cycle. We also
tested the hypothesis that Opa variants have an adherence
advantage or survive better early in infection due to increased
resistance to host complement. Our data demonstrated the
importance of Opa protein expression for persistence of N.
gonorrhoeae in the female genital tract and also provide a novel
example of how the evolution of a bacterial species has been
fine-tuned by the mammalian reproductive cycle.
MATERIALS AND METHODS
Bacterial strains. N. gonorrhoeae strain FA1090 (porB1b, streptomycin resis-
tant, serum resistant) was originally isolated from a female patient with dissem-
inated gonococcal infection. Strain FA1090 has been extensively characterized
using male volunteers (10, 29, 51). Strain FA1090F62por5-8 is a serum-sensitive
derivative of strain FA1090 that does not bind human C4B-binding protein
(C4BP) due to replacement of porin loops 5 to 8 with loops 5 to 8 of the
serum-sensitive strain F62 (46) (kindly provided by Sanjay Ram, University of
Massachusetts). Frozen stocks containing mostly piliated or nonpiliated colony
variants of wild-type strain FA1090 or strain FA1090F62por5-8 were prepared by
single-colony purification and colony suspension immunoblotting using antibod-
ies specific to the Opa proteins of strain FA1090, as described previously (29, 52).
Strains FA1090opaA-K and FA1090opaA-K(B) were kindly provided by Janne
Cannon, University of North Carolina. Strain FA1090opaA-K is an unmarked
recombinant strain derived from wild-type strain FA1090 in which all 11 opa
loci were insertionally inactivated via a selection-counterselection method
(33) or single-step allelic exchange (17). Strain FA1090opaA-K(B) is strain
FA1090opaA-K carrying a phase-locked opaB gene. To create a locked-on
opaB gene, we altered the opaB signal peptide-encoding region by replacing
the coding repeats with nonrepeating nucleotides that encode the same
amino acids. Plasmid pFLOB605, which is plasmid pBR322 carrying a cloned
opaB gene from strain FA1090, was used as a template for site-directed
mutagenesis (QuikChange kit; Stratagene). Mutagenesis using the RDELCR
(5-GCCTTCACTTGCCGCCTGCGCTGCACTAGTAGAGAAGGTTTTTT
GCGGGCTGGATTC-3) and FDELCR (5-GAATCCAGCCCGCAAAAAAC
CTTCTCTACTAGTGCAGCGCAGGCGGCAAGTGAAGGC-3) oligonucleo-
tides resulted in deletion of 50 bp encompassing the coding repeats and creation
of an SpeI restriction site (underlined in the sequences above). To create re-
placement nucleotides encoding a non-phase-variable signal peptide, the an-
nealed oligonucleotide duplex linkers SIG1 (5-TTATTCAGCAGCTTGCTGT
TCAGCTCATTACTGTTCAGCTCACTGTC-3) and SIG2 (5-GACAGTGA
GCTGAACAGTAATGAGCTGAACAGCAAGCTGCTGAATAA-3) were
ligated into the SpeI site following removal of the 5 CTAG extension by diges-
tion with mung bean nuclease. However, all of the plasmids that we recovered
following transformation into Escherichia coli DH5 had frameshift mutations in
the signal peptide-encoding region, suggesting that the opaB gene product was
toxic. To eliminate expression from the native opaB promoter, we PCR amplified
a region extending from the 10 region to the 3 end of the opaB coding
sequence using a clone with a frameshift deletion as the template and the PREco
(5-GAGAATTCGCCCTTCAACATCAGTG-3) and PRBam (5-GAGGATC
CGACATCGTGCTTGCCGAC-3) oligonucleotides. The resultant PCR prod-
uct was digested with EcoRI and BamHI and ligated into pBR322. The correct
reading frame was restored by insertion of a single thymine 78 bp downstream
from the start of the opaB coding region. The resultant plasmid was used for
allelic exchange of the insertionally inactivated opaB locus in FA1090opaA-K.
The lack of Opa protein expression by the FA1090opaA-K mutant and the
constitutive expression of OpaB by FA1090opaA-K(B) bacteria were con-
firmed by colony suspension immunoblotting. The lipooligosaccharide (LOS)
phenotypes were similar for all Opa variants of strains FA1090 and
FA1090F62por5-8 tested and for strains FA1090opaA-K and FA1090opaA-K(B)
based on comparisons of the banding patterns of proteinase K-treated digests
(24) fractionated on 4 to 12% bis-Tris gradient gels (Invitrogen), followed by
silver staining.
Culture conditions. All N. gonorrhoeae strains were cultured at 37°C under 7%
CO2 on GC agar with Kellogg’s supplement I and 12 M Fe(NO3)3 or on GC
agar supplemented with vancomycin, colistin, nystatin, trimethoprim sulfate, and
streptomycin (VCNTS) for mouse experiments, as described previously (28).
Growth curves were determined by growing bacteria at 37°C in supplemented
GC broth (GCB) with 0.5 mM NaHCO3 with agitation. At hourly time points,
aliquots were diluted in GCB with 0.05% saponin to break up aggregates and
quantitatively cultured overnight on GC agar. Where indicated below, water-
soluble 17-estradiol (17-estradiolws) (Sigma) was added to liquid cultures at a
final concentration of 1,000, 100, or 10 pg/ml.
Tissue culture assay. ME180 human cervical epithelial cells and HEC1B
human endometrial cells were obtained from ATCC. ME180 cells were cultured
in McCoy’s 5A medium supplemented with 10% fetal bovine serum (FBS) and
2.2 g/liter sodium bicarbonate. HEC1B cells were cultured in Dulbecco modified
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Eagle medium (DMEM) with 10% FBS at 37°C with 5% CO2. Two mouse
epithelial cell lines, IEC 4.1 (intestinal) and BM1.11 (oviduct) (generously pro-
vided by Harlan Caldwell [Rocky Mountain Laboratories, Hamilton, MT] and
Raymond Johnson [Indiana University School of Medicine, Indianapolis, IN],
respectively) were cultured as described previously (48). All tissue culture cells
were maintained with 50 g/ml gentamicin (Gm) during routine passage. For
adherence and invasion assays, cells were seeded at a density of 1  105 cells per
well in 24-well tissue culture plates in the absence of antibiotics and infected the
following morning with FA1090opaA-K or FA1090opaA-K(B) bacteria. The
bacteria were suspended to an A600 of 0.07 in phosphate-buffered saline (PBS)
and diluted 1:10 in RPMI with 10% FBS and 0.2 M Fe(NO3)3. Five hundred
microliters (3  106 to 4  106 CFU) was applied to each of the cell monolayers
to obtain the desired multiplicity of infection (MOI) (30 to 40). For adherence
assays, monolayers were incubated with bacteria for 2 h at 37°C under 7% CO2
and washed four times with PBS to remove nonadherent bacteria. Cells were
lysed with 0.5% saponin, and the number of cell-associated bacteria was deter-
mined by serial dilution and culture. For invasion assays, monolayers were
incubated with bacteria for 2 h and washed twice with PBS. Gm (50 g/ml) was
then added, and the cells were incubated for 1.5 h. Monolayers were washed five
times with PBS and lysed with 0.5% saponin, and the number of internalized
bacteria was determined after serial dilution and culture. The results are ex-
pressed below as the percentage of cell-associated bacteria relative to the inoc-
ulum (adherence) or the percentage of Gm-protected bacteria relative to the
number of adherent bacteria (invasion). All conditions were analyzed in tripli-
cate in an experiment, and each experiment was performed three times.
Bactericidal assays. The bactericidal activity of normal human serum (NHS)
against colony-purified Opa variants of strain FA1090F62por5-8 was tested using a
microtiter plate assay essentially as described previously (18). Briefly, NHS
(Quidel) or heat-inactivated NHS (HI-NHS) was serially diluted in minimal
essential medium (MEM) to obtain a final serum concentration of 0.5 to 8%.
Bacteria that were 18 to 22 h old were harvested from agar plates, suspended in
PBS to an A600 of 0.07, and diluted 1:2,000 in MEM. Thirty microliters (1.5 
103 CFU) of each suspension was added to each well, and the plates were
incubated for 1 h at 37°C with 5% CO2. Fifty microliters of GC broth was then
added to all wells, and a 30-l aliquot from each well was cultured on GC agar.
Colonies were enumerated after 24 h, and the results were expressed as the
percent survival (100  [number of CFU recovered from NHS-containing wells/
number of CFU recovered from wells with the same concentration of HI-NHS]).
The percent survival was plotted versus the dilution of NHS to determine the
50% bactericidal titer, which was defined as the dilution of NHS that resulted in
survival of 50% of the bacteria. In other experiments, the percent survival values
for different Opa variants following exposure to 3% NHS were determined based
on a comparison with the results obtained with HI-NHS. No killing was observed
with HI-NHS in any experiment.
Protease inhibition assay. The sensitivities of wild-type Opa variants and
strains FA1090opaA-K and FA1090opaA-K(B) to bovine trypsin and -chymo-
trypsin (Sigma) were measured by the disk diffusion assay using 6-mm disks and
the method described previously (57), with the modification that 2-fold increas-
ing concentrations of each protease (2.5 mg/ml to 40 mg/ml) were tested to
determine the dose response. The average zone of inhibition for each concen-
tration was calculated from the data for triplicate plates after 18 h of incubation.
Experimental murine infection. Female intact and ovariectomized (Ov)
BALB/c mice that were 4 to 6 weeks old (National Cancer Institute, Frederick,
MD) were housed with a regimen consisting of 12 h of light and 12 h of darkness
and were given food and water ad libitum. The ovaries of Ov mice were
surgically removed at least 14 days prior to the start of the experiment, and all
mice were allowed to acclimate to the Uniformed Services University of the
Health Sciences (USUHS) animal facility for 10 to 14 days before the start of an
experiment. There are four stages of the murine estrous cycle (proestrus, estrus,
metestrus, and diestrus), which can be differentiated by cytological examination
of stained vaginal smears. To promote long-term infection with N. gonorrhoeae,
diestrus-stage mice were treated with 17-estradiol via implantation of a 5-mg,
21-day slow-release pellet (Innovative Research of America) (28) for experi-
ments designed to compare Ov and intact mice, the recombinant strains
FA109opaA-K and FA109opaA-K(B), and the effects of complement compo-
nent 3 (C3) depletion. In two experiments, estradiol was administered via sub-
cutaneous injection of 17-estradiolws (total dose, 1.5 mg) instead of pellets (56).
Antibiotics were administered to mice under both treatment regimens as de-
scribed previously (30). Mice were inoculated vaginally with bacteria 2 days after
pellet implantation or after the second dose of 17-estradiolws (28, 56). In some
experiments, antibiotics but no estradiol were given, and transient colonization
was achieved by inoculating mice in the proestrus stage with N. gonorrhoeae. In
these experiments, soiled litter from a cage containing male mice was used to
promote synchronization of the cycle (12).
For all mouse infection experiments, mice were inoculated vaginally with 20 l
(106 CFU) of a filtered bacterial suspension in PBS, and vaginal mucus was
quantitatively cultured for N. gonorrhoeae on GC-VCNTS agar as described
previously (28). In experiments with wild-type strain FA1090 bacteria, the inoc-
ula consisted of mostly nonpiliated colony-purified variants of Opa and OpaB-
expressing gonococci harvested from solid GC agar after 20 h of incubation.
Nonpiliated variants were used to minimize the aggregation of Opa variants,
which can interfere with accurate quantitation. Piliation is not required for
experimental murine infection, and we previously showed that selection for Opa
protein expression occurs during infection regardless of whether gonococci are
piliated (28). Suspensions of variants were combined to obtain ratios of 10 to
20% OpaB-expressing variants versus 80 to 90% Opa variants as described
previously (52). The Opa phenotypes of 96 colonies isolated from each inoculum
or of 36 colonies cultured from vaginal mucus from each mouse at each time
point were determined by colony suspension immunoblotting (limits of detection
for the Opa phenotypes, 1% and 3%, respectively) (28, 52). The results were
expressed as the fold increases in the levels of the Opa variants relative to the
inoculum. The OpaB and OpaD variants and the OpaE and OpaK variants were
not distinguished and therefore are referred to below as the OpaB/D and
OpaE/K variants, respectively. The multiple expression phenotype in which two
phenotypes are expressed simultaneously is referred to as OpaB,I for OpaB and
OpaI, etc., throughout.
C3 capture ELISA and complement depletion studies. To measure vaginal C3
levels, vaginal washes were collected from uninfected BALB/c mice 3 days after
implantation of a 5-mg 17-estradiol pellet and then daily for the next 7 days.
Antibiotics were also administered to mice per the infection protocol. Washes
were obtained by pipetting 40 l of PBS in and out of the vagina five times, and
three washes were combined to obtain a total of 120 l for each mouse. Vaginal
washes were centrifuged at 13,000 rpm for 3 min to remove cellular debris, and
the supernatant was frozen at 20°C. The concentration of C3 in vaginal washes
was determined by a capture enzyme-linked immunosorbent assay (ELISA)
(GenWay Biotech Inc.) performed according to the manufacturer’s specifica-
tions. To study the effect of complement on the early phase of infection, cobra
venom factor (CVF) (Quidel) was administered intraperitoneally to groups of
estradiol-treated mice (20 g CVF per 18- to 21-g mouse) to deplete C3 the day
before bacterial inoculation. A PBS-treated control group was tested in parallel.
To study later time points, estradiol-treated mice were colonized with bacteria
for 4 days and then treated with CVF or PBS. For all C3 depletion studies, the
numbers of bacteria recovered from CVF-treated mice and from PBS-treated
mice each day for 3 days after treatment were compared. Serum was collected by
centrifugation of whole blood obtained by retro-orbital bleeding at 18 and 72 h
after each CVF dose, and the C3 concentration was determined by the capture
ELISA as described above. The serum C3 levels were 1 mg/ml in normal mice
and were 90 to 95% lower in CVF-treated mice. In pilot studies to determine the
optimum dose and concentration of CVF, C3 levels decreased within 8 h after
administration of 20 g of CVF and remained low for at least 72 h. All exper-
iments were performed at least twice to test reproducibility.
Animal use. Animal experiments were conducted in the laboratory animal
facility at USUHS, which is fully accredited by the Association for the Assess-
ment and Accreditation of Laboratory Animal Care, using a protocol approved
by the USUHS Institutional Animal Care and Use Committee.
Statistical analysis. For tissue culture experiments, bactericidal assays, pro-
tease inhibition assays, and comparisons of C3 levels in vaginal washes, an
unpaired Student t test was used to assess statistical significance. A two-way
analysis of variance (ANOVA) followed by an unpaired Student t test was used
to determine if there was a difference in the numbers of gonococci recovered
from infected mice or a difference in the fold changes in recovery of Opa
variants. The log rank test was used to assess the difference in duration of
infection between recombinant strains FA1090opaA-K and FA1090opaA-K(B).
For all analyses, a P value of 	0.05 was considered significant.
RESULTS
The cyclical recovery pattern is not dependent on estradiol
treatment. N. gonorrhoeae strain FA1090 expresses 8 antigeni-
cally distinct Opa proteins (OpaA, -B, -C, -D, -E, -F, -K, and
-I). We demonstrated previously that Opa variants of strain
FA1090 were selected early during infection (days 1 to 3) of
estradiol-treated BALB/c mice. In these experiments, mice
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were inoculated with a bacterial suspension containing pre-
dominantly Opa variants that was spiked with a lower per-
centage of Opa variants. This early selection phase was fol-
lowed by an increase in the proportion of Opa variants on
days 5 to 7 (middle phase) and subsequent isolation of pre-
dominantly Opa variants on days 9 to 11 (late phase). The
changes in the total numbers of gonococci recovered from
vaginal swabs mirrored the shifts in Opa phenotype, with
higher numbers corresponding to time points at which Opa
gonococci predominated and a period of decreased recovery
corresponding to the middle phase. We described the observed
changes in the percentage of Opa variants and the total
number of CFU recovered as the cyclical recovery pattern (52).
The cyclical recovery pattern was first described in studies
using mice that were under the influence of high concentra-
tions of estradiol for at least 2 weeks due to the implantation
of slow-release 17-estradiol pellets to promote susceptibility
to infection. Estradiolws also promotes susceptibility to N. gon-
orrhoeae, but the serum estradiol levels return to physiological
concentrations within 24 h after administration (56). To deter-
mine whether the cyclical recovery pattern also occurs in mice
that are not under the influence of sustained, nonphysiological
concentrations of estradiol, we inoculated estradiolws-treated
mice with a defined bacterial suspension that consisted of 89%
Opa variants, 11% OpaB variants, and 	1% other Opa
variants and determined the Opa phenotypes of colonies iso-
lated from vaginal mucus over time. Three- and 7-fold in-
creases in the proportion of Opa variants compared to the
proportion of Opa variants in the inoculum were observed on
days 1 and 2 postinoculation, respectively (Fig. 1A). Decreases
in the proportion of Opa variants occurred on days 3 to 5
postinoculation (middle phase), and this was followed by an
increase in the proportion of Opa variants compared to the
proportion in the inoculum (late phase). As seen with pellet-
treated mice, the changes in the relative proportion of Opa
variants in the middle and late phases were accompanied by a
decrease and an increase in the average number of gonococci
recovered, respectively (data not shown).
The distribution of Opa phenotypes among primary vaginal
isolates from estradiolws-treated mice was also consistent with
the previously observed recovery pattern. All mice selected for
variants that expressed OpaB early in infection, and higher
proportions of gonococci that expressed more than one Opa
protein were recovered in the late phase. An example of the
distribution of Opa variants in vaginal isolates from one rep-
resentative mouse is shown in Fig. 1A (pie charts). In this
example, OpaB (pink areas) and OpaB,I (pink and blue striped
areas) variants predominated in vaginal isolates on days 1 and
2 postinoculation. This early phase was followed by a 3-day
period in which the relative proportion of Opa variants re-
covered decreased (middle phase). Increased recovery of
gonococci that express OpaB,I and other Opa phenotypes
then occurred on days 6 and 7 (late phase), and in this mouse
evidence of a second middle phase was observed on day 8.
Untreated mice can support transient colonization with N.
gonorrhoeae when they are challenged in the proestrus stage of
the estrous cycle (12, 31). We therefore also examined the
selection kinetics for Opa variants in mice that were not
treated with estradiol. While not as pronounced as the data
obtained for estradiolws-treated mice, the combined data from
three independent experiments with untreated mice showed
that there was a 2-fold or greater increase in the proportion of
Opa variants in vaginal isolates compared to the proportion
in the inoculum at day 1 postinoculation. This increase oc-
curred in 8 of 11 mice (Fig. 1B). The average percentage of
Opa isolates declined to a value that was less than 2-fold
greater than the value obtained for the inoculum on days 2 and
3 postinoculation, and there was clearly a middle phase in 3 of
5 mice. The middle phase was followed by dramatic increases
in the percentage of Opa variants (3.5- and 6-fold) isolated
from the two mice that remained colonized for 4 days.
The Opa phenotypes of vaginal isolates from one infected
untreated mouse are shown in Fig. 1B (pie charts). Following
inoculation with a population of bacteria that consisted of 87%
Opa, 11% OpaB, 1% OpaA, and 1% OpaE/K variants, 45%
of the primary vaginal isolates from this mouse were Opa on
the first day after inoculation, and several different Opa vari-
ants were represented. Following a decrease in the relative
number of Opa variants on days 2 and 3, 83% of the isolates
on day 4 expressed one Opa protein (solid colors) or several
Opa proteins simultaneously (striped patterns), and the ma-
jority of the isolates expressed OpaI (dark blue area). A similar
pattern was observed in a second mouse that was colonized
through day 4, although the predominant Opa phenotype on
day 4 was OpaE/K (69% of isolates). These results are consis-
tent with the three phases of recovery seen in estradiol-treated
mice and show that Opa-expressing variants have a clear ad-
vantage in vivo over time.
The timing of each phase of the recovery pattern was dif-
ferent in untreated, pelleted, and estradiolws-treated mice. Ad-
ditionally, the early and middle phases observed in untreated
mice were less dramatic than those observed in estradiolws-
treated mice (Fig. 1A). The latter observation could have been
due to the fact that the appearance and subsequent loss of the
selective factor may be more rapid or less uniform in untreated
mice than in estradiol-treated mice. Alternatively, estradiol
itself may select for Opa expression, which could explain the
differences in degree of selection and selection kinetics in these
three different experimental models. We therefore tested
whether estradiol directly selects for Opa variants in vitro. We
found no change in the proportion of Opa variants relative to
the proportion in the starting inoculum when a suspension of
primarily Opa gonococci was cultured in broth that contained
17-estradiol at concentrations that are similar to the peak
serum estradiol levels in pellet-treated, estradiolws-treated, and
untreated mice (Fig. 1C). We concluded there is an endoge-
nous host factor in the lower genital tract of female mice that
selects for distinct subpopulations with different Opa pheno-
types in a cyclical pattern. Estradiol itself is not directly re-
sponsible for the pattern observed, although the selective fac-
tor(s) appears to be modulated in vivo by the administration of
17-estradiol.
The cyclical recovery pattern is dependent on the ovaries.
Cyclical fluctuations in the number of gonococci cultured from
vaginal mucus and in the Opa phenotype of vaginal isolates
suggests that hormonal factors challenge N. gonorrhoeae dur-
ing murine infection. Ovariectomiced (Ov) mice can be in-
fected with N. gonorrhoeae, although 17-estradiol and antibi-
otic treatment is required (30), and these mice can be used to
study different aspects of gonococcal infection in the absence
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FIG. 1. For both estradiol-treated and untreated mice there was cyclical recovery of Opa variants, and estradiol does not select for Opa
protein expression in vitro. For mice treated with 17-estradiolws (A) or not treated with estradiol (B) there was cyclical recovery of Opa
 variants
after the mice were inoculated with a defined suspension containing predominantly Opa variants. The average fold increases for Opa variants
among vaginal isolates compared to the inoculum are indicated in the histograms, and selection was defined as a 2-fold increase (dotted line).
The bars indicate standard errors of the means; the asterisks indicate that the P value is 	0.03 for a comparison with the value for the middle phase,
which was defined as days 3 to 5 for panel A and as day 3 for panel B. The results in panel A are the results of one experiment performed with
6 mice inoculated with 89% Opa and 11% OpaB variants and are representative of two independent experiments (5 or 6 mice per experiment).
The data in panel B are combined data from three experiments in which untreated mice were colonized for 1 to 4 days. The average fold increase
was based on the results for 11 mice on day 1, for 5 mice on day 2, for 3 mice on day 3, and for 2 mice on day 1. In each panel the pie charts show
the Opa phenotype of a representative mouse, and the colors indicate the different Opa proteins of strain FA1090. The striped patterns show the
results for variants that express multiple Opa proteins. (C) Recovery of Opa isolates from a liquid culture at different stages of growth, expressed
as fold increases compared to the inoculum. GCB with no estradiol or with 10, 100, or 1,000 pg/ml 17-estradiolws was inoculated with a bacterial
suspension that contained 75% Opa variants. Concentrations were based on serum estradiol levels in untreated, pellet-treated, and estradiolws-
treated mice (56). The Opa phenotypes of 96 colonies (zero time) and 36 colonies (6 and 8 h) isolated from each culture at different time points
were determined, and the fold changes compared to the inoculum are indicated. No change in the Opa phenotype was observed under any
conditions. OD600, optical density at 600 nm.
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of the reproductive cycle. To test the role of the reproductive
cycle in the cyclical recovery pattern, we inoculated estradiol-
treated intact and Ov mice with a defined suspension con-
taining primarily Opa variants and determined the numbers
of CFU recovered and the Opa phenotypes of vaginal isolates
over time. Selection for Opa variants occurred in both intact
and Ov mice on day 1 of infection. The cyclical recovery
pattern was then observed in intact mice, as expected, with
increased percentages of Opa variants in the early and late
phases (Fig. 2A) corresponding to periods when there were
increased numbers of recovered total CFU (Fig. 2B). In con-
trast, selection for Opa gonococci was maintained in Ov
mice (Fig. 2A), and the number of gonococci recovered was
constant throughout the 15-day experiment (Fig. 2B). We con-
cluded that changes in Opa protein selection and the coloni-
zation load, which together define the cyclical recovery pattern,
are influenced directly or indirectly by ovarian factors.
Opa proteins provide a colonization advantage in both the
early and late stages of infection. Due to the strong selection
for Opa gonococci in the early phase of infection, we hypoth-
esized that Opa protein expression confers an advantage soon
after bacteria enter the vagina and that Opa gonococci would
not colonize mice as well as Opa-expressing gonococci. To test
this hypothesis, we utilized a genetically defined mutant of
strain FA1090 in which all of the opa genes were inactivated
(FA1090opaA-K) and a derivative of this Opa-deficient mu-
tant into which a phase-locked opaB gene was reintroduced
[FA1090opaA-K(B)]. The growth kinetics of strains
FA1090opaA-K and FA1090opaA-K(B) were similar when
these organisms were cultured in liquid media (Fig. 3A).
Therefore, next we compared the capacities of these two
strains to infect estradiol-treated mice. Mice were inoculated
with 106 CFU of one of these strains, and vaginal mucus was
cultured over time. Consistent with the hypothesis that Opa
protein expression confers a colonization or survival advantage
early during infection, a higher number of bacteria was recov-
ered from mice inoculated with the OpaB-expressing strain on
day 1 than from mice inoculated with the Opa-deficient strain
(P 	 0.05) (Fig. 3B). There was a decrease in the number of
bacteria recovered in both groups on days 4 to 7, which is
typical of the middle phase. A steady increase in the recovery
of OpaB-expressing bacteria then began on day 8 and lasted
through day 14 in 12/16 mice, which is temporally consistent
with the late phase. The number of gonococci recovered was
significantly higher for mice inoculated with the OpaB-express-
ing strain than for mice inoculated with the Opa-deficient
mutant on days 9 to 12 and 14 (P 	 0.05). Additionally, in
contrast to the results for the mice infected with the OpaB-
expressing strain, the increase in the number of CFU that
typifies the late stage occurred in only 5/16 mice infected with
the Opa-deficient strain following this period of reduced bac-
terial recovery. A comparison of the colonization curves fur-
ther demonstrated that strain FA1090opaA-K(B) was more
fit than strain FA1090opaA-K in terms of establishing persis-
tent infection; on day 14 69% and 31% of mice were infected
with these strains, respectively (P 
 0.037) (Fig. 3C).
These results are the first demonstration of the importance
of Opa proteins during infection using defined mutants in an in
vivo model. We concluded that (i) OpaB provides an early
advantage during infection of female mice, (ii) the factors that
are responsible for the decreased recovery of viable bacteria in
the middle phase appear to be Opa independent based on the
decreased recovery of both the Opa-deficient and Opa-ex-
pressing strains on days 5 to 8 postinoculation, and (iii) Opa-
deficient gonococci are less able to recover from the middle
phase, presumably due to a factor that appears later in infec-
tion, which gives Opa-expressing gonococci a selective advan-
tage in vivo.
OpaB does not mediate invasion of murine tissue culture
cells. In addition to members of the human CEACAM family,
other receptors for Opa-mediated adherence and uptake have
been described (for reviews, see references 13 and 40). The
presence of an Opa-specific colonization receptor in the mu-
rine lower genital tract could explain the in vivo selection for
Opa-expressing bacteria. Immortalized murine epithelial cells
of vaginal, cervical, or endometrial origin have not been de-
scribed; therefore, to examine this hypothesis, we compared
FIG. 2. Normal (intact) mice, but not Ov mice, show a cyclical re-
covery pattern. Five-milligram 17-estradiol pellets were implanted in
members of groups of intact or Ov mice, and the mice were inoculated
with 106 CFU of a suspension containing 70% Opa, 23% OpaB, 3%
OpaC, 2% OpaF, and 1% OpaF and OpaI variants. The Opa phenotype
of vaginal isolates and the number of gonococci recovered were deter-
mined over time. (A) Opa phenotype of vaginal isolates. Selection for
Opa expression, which was defined as a 2-fold increase in the percent-
age of Opa variants compared to the inoculum, occurred in both groups
on day 1. However, the subsequent loss and reemergence of Opa vari-
ants that occurred in intact mice did not occur in Ov mice. (B) Total
number of CFU recovered over time. Fluctuations in the total number of
CFU recovered from vaginal swab suspensions were observed in intact
mice, as reported previously (47), and the dramatic decline that charac-
terized the middle phase occurred on days 5 to 8. Ov mice showed more
uniform recovery of viable gonococci over time. An asterisk indicates a
significant difference (P 	 0.05) between the numbers of gonococci re-
covered from groups, and the error bars indicate the standard errors of
the means. In the experiment whose results are shown, there were 3 mice
per group, except for intact mice on days 11 to 15, for which results for 2
mice are shown. The third mouse was not colonized at these time points.
The results were consistent in a second experiment performed with 5 mice
per group.
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the capacities of the OpaB-expressing strain FA1090opaA-
K(B) and the Opa-deficient strain FA1090opaA-K to adhere
to and invade murine IEC4.1 (intestinal) and BM1.11 (ovi-
duct) cells. We also tested the ME180 cell line, which is a
CEACAM-expressing human endocervical cell line, and the
HEC1B cell line, which is a human CEACAM-negative endo-
metrial cell line that supports Opa-dependent invasion (59), as
controls. Both human cell lines supported Opa-dependent in-
vasion, as shown by the fact that significantly more OpaB-
expressing bacteria than Opa-deficient bacteria were recovered
following Gm treatment (Fig. 4). Tenfold more internalized
OpaB-expressing gonococci were recovered from ME180 cells
than from HEC1B cells, a result that is consistent with Opa
protein-CEACAM interactions mediating more efficient up-
take. There was no difference in the numbers of gonococci
recovered from IEC4.1 and BM1.11 murine cells following Gm
treatment (Fig. 4). This result suggests that murine cells do not
support Opa-dependent invasion. We also found no difference
in the capacities of the Opa and Opa strains to adhere to
IEC4.1 or BM1.11 cells, and the numbers of cell-associated
bacteria were similar for murine and human epithelial cells
(data not shown). These results are inconsistent with the hy-
pothesis that the in vivo advantage exhibited by strain
FA1090opaA-K(B) was due to OpaB-mediated adherence or
invasion. However, we cannot rule out the possibility that Opa-
specific colonization receptors may be expressed by epithelial
cells in the murine genital tract during infection.
C3 depletion does not affect the early selection phase. Hor-
monal regulation of complement levels in the female genital
tracts of humans (21) and mice (36) is well established, and
Bos et al. (5) reported that Opa variants of N. gonorrhoeae
strain MS11 were more resistant to the bactericidal activity
of low concentrations of NHS. Strain FA1090, in contrast to
strain MS11, is highly resistant to NHS, and our attempts to
demonstrate Opa-mediated increases in serum resistance in
strain FA1090 were unsuccessful. The high level of serum
resistance in strain FA1090 is due to porin-mediated bind-
ing of human C4b-binding protein (C4BP) (46). Be-
cause this form of serum resistance is host restricted (41)
FIG. 3. OpaB-expressing strain colonizes 17-estradiol-treated
mice better than Opa-deficient mutant. The Opa-deficient strain
FA1090opaA-K and the OpaB-expressing strain FA1090opaA-K(B)
were compared to examine differences in growth in liquid culture and
the capacity to colonize estradiol-treated mice. (A) Optical density at
600 nm (OD600) for GCB cultures inoculated with FA1090opaA-K or
FA1090opaA-K(B) bacteria over time. (B) Average number of CFU
recovered by vaginal swabbing following inoculation of estradiol-
treated mice with 106 CFU of Opa-deficient or OpaB-expressing bac-
teria. The error bars indicate the standard errors of the means, and the
asterisks indicate significant differences between groups (P 	 0.05,
Student’s t test). (C) Percentage of mice colonized on each day fol-
lowing inoculation with strain FA1090opaA-K and with strain
FA1090opaA-K(B). Significantly more mice were culture positive
following inoculation with the constitutive OpaB-expressing strain
than following inoculation with the Opa-deficient strain (P 
 0.037, log
rank test). The results in panels A and B are results from two com-
bined experiments, and each symbol represents 16 mice.
FIG. 4. OpaB-mediated invasion occurs in immortalized human
tissue culture cells but not in murine tissue culture cells. The capacities
of strains FA1090opaA-K(B) and FA1090opaA-K to invade human
(ME180 and HEC1B) and mouse (IEC4.1 and BM1.11) cells were
compared using the Gm protection assay. A higher number of
FA1090opaA-K(B) CFU than of FA1090opaA-K CFU was recovered
from both human cell lines after Gm treatment, and there was 10-fold-
greater internalization of the Opa-expressing strain by the CEACAM-
expressing ME180 cells than by the CEACAM-negative HEC1B cells.
No difference in invasion was detected in either mouse cell line for
FA1090opaA-K(B) or FA1090opaA-K. No difference in the number
of cell-associated gonococci was observed between the two strains for
any cell line (data not shown). The level of invasion was calculated by
comparison with the number of adherent bacteria recovered before
Gm treatment (data not shown). The error bars indicate the standard
errors of the means for three independent wells. Similar results were
obtained in three independent experiments.
VOL. 78, 2010 SELECTION FOR Opa PROTEINS IS UNDER OVARIAN CONTROL 1635
and does not occur during murine infection, it seemed pru-
dent to further investigate the role of Opa proteins in evad-
ing host complement in a serum-sensitive strain. We there-
fore utilized strain FA1090F62por5-8, which is a serum-
sensitive derivative of strain FA1090 that does not bind
human C4BP due to an altered porB gene. Gonococci that
express OpaA, OpaB, OpaE/K, OpaF, or OpaI are fre-
quently isolated from mice (28, 52), and therefore OpaA,
OpaB, OpaE/K, and OpaF variants were isolated from
strain FA1090F62por5-8 for these studies. OpaI variants,
which aggregate at a high level and thus form very opaque
colonies, were not used due to the risk that clumping would
interfere with the results. We also isolated variants that
express two or three Opa proteins simultaneously to mea-
sure the effect of the multiple-expression phenotype on se-
rum resistance. The 50% bactericidal titers of NHS ranged
from 1.8% (Opa, OpaA, and OpaA,B) to 5.1% (OpaA,F
and OpaA,F,E/K) when the results of assays in which two to
four different variants of strain FA1090F62por5-8 were tested
(Fig. 5A). As titration of the bactericidal activity of serum is
too labor-intensive to test all variants in the same experi-
ment, we also tested a single concentration of NHS, 3%,
which fell in the linear region of the bactericidal curves. A
similar resistance gradient was observed, although only
OpaF, OpaA,F, and OpaA,F,E/K variants were statistically
more resistant to NHS than Opa variants when combined
results from at least three independent experiments were
compared (P 	 0.001) (Fig. 5B). A multiple-expression phe-
notype (OpaA,F and OpaA,F,E/K) did not increase serum
resistance compared to expression of OpaF alone when 3%
NHS was tested.
Murine complement is very labile, and thus mouse serum
cannot be used to test the bactericidal activity of low concen-
trations of complement, such as the concentration which is
present at mucosal surfaces. To further analyze the role of
complement as a selective factor for Opa protein expression,
we measured the level of C3 in vaginal washes from uninfected,
estradiol-treated mice. In two experiments, the average vaginal
C3 concentration appeared to decline at the time point that
corresponded to day 2 of infection and then gradually in-
creased through day 8, although there was great variability
among mice and no statistically significant differences between
time points were detected (Fig. 6A). This result suggests that
the basal levels of complement are highest at the time points
that correspond to the early and late phases of infection. To
more directly test the potential of complement to select for
Opa variants during infection, we next treated mice with
cobra venom factor (CVF) on the day prior to inoculation to
deplete C3 and then challenged them with a suspension of
wild-type gonococci that contained 80% Opa variants. A
2-fold increase in the level of Opa variants occurred on day 1
or 2 postinoculation in the CVF-treated group and the PBS-
treated control group, a result that suggests that complement
does not mediate the selection for Opa expression that occurs
early in infection (Fig. 6B). We also inoculated mice treated
with CVF or PBS as described above with the Opa-deficient
strain, predicting that the level of recovery of the mutant would
increase in the early phase of infection if Opa gonococci were
susceptible to complement in vivo. We found no difference in
the numbers of CFU recovered from CVF-treated mice and
from PBS-treated mice on days 1 to 3 (Fig. 6C). From these
results, we concluded that complement does not select for Opa
protein expression in the early phase of the cyclical recovery
pattern.
Wild-type Opa variants and the constitutive OpaB-ex-
pressing strain are more susceptible to growth inhibition by
serine proteases. Several proteases are differentially expressed
during the mammalian reproductive cycle (34). Proteases may
challenge Opa gonococci more than Opa gonococci during
infection based on reports by Swanson and colleagues that
gonococci in opaque colonies were more sensitive to the serine
proteases than transparent variants (3, 27, 57). As several Opa
proteins of strain FA1090 (OpaB, OpaE, and OpaK) do not
confer detectable photoopacity to a colony, we reexamined this
hypothesis using bacteria with known Opa phenotypes. Con-
FIG. 5. Expression of some FA1090 Opa proteins is associated with
increased resistance to NHS. The bactericidal activity of NHS was
tested using different Opa variants of the serum-sensitive derivative
FA1090F62por5-8. (A) Plot of the level of survival of each variant tested
versus the dilution of NHS tested. The representative data from sev-
eral independent assays show that there was an increase in the 50%
bactericidal titer compared to the 50% bactericidal titer for Opa
variants for gonococci that express OpaB, OpaE/K, OpaF, OpaA,F,
and OpaA,F,E/K but not for variants that express OpaA or OpaA,B.
The 50% bactericidal titers were 1.8% (Opa, OpaA, and OpaA,B),
2.2% (OpaB), 3.4% (OpaE/K), 3.8% (OpaF), and ca. 5.1% (OpaA,F
and OpaA,F,E/K). (B) Levels of survival of different Opa variants
following incubation in 3% NHS. The results are expressed as the
average levels of survival when data from at least three independent
experiments were combined. The error bars indicate the standard
errors of the means, and the asterisks indicate that there was a signif-
icant difference (P 	 0.0001). The level of survival was calculated by
dividing the number of CFU recovered from wells with NHS by the
number of CFU recovered from wells with the same concentration of
HI-NHS and multiplying by 100.
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sistent with the previous report, the Opa-deficient strain
FA1090opaA-K was less susceptible than the complemented
OpaB-expressing strain to growth inhibition when a trypsin
concentration of 10 mg/ml or 20 mg/ml was used (Fig. 7A). A
broader dose response was observed when -chymotrypsin was
tested, and statistically significant differences were detected at
concentrations of 2.5 mg/ml. We also found that OpaA,
OpaB, and OpaD wild-type variants were more susceptible to
-chymotrypsin than Opa-negative gonococci (Fig. 7B). Be-
cause Opa gonococci are selected for in vivo, we hypothesize
that protease inhibitors, which can also fluctuate over the
course of the reproductive cycle (34), may protect Opa gono-
cocci from proteases expressed early and late in infection. This
hypothesis does not adequately explain the selection for Opa
expression that was observed in vivo, however, since presum-
ably Opa gonococci would also be protected by protease
inhibitors.
DISCUSSION
The capacity to maintain reservoirs of bacteria that differ in
expression of surface molecules is a major adaptation mecha-
nism of N. gonorrhoeae. The neisserial Opa proteins exhibit
phase-variable expression, and we previously reported cyclical
recovery of Opa variants from the lower genital tract of
female mice (52), a result that is consistent with Opa and
Opa phenotypes having distinct roles during infection. Here
we showed that administration of estradiol, which is used to
promote susceptibility to N. gonorrhoeae in mice, is not re-
quired for cyclical recovery of Opa gonococci. We also
showed that early selection for Opa expression also occurs in
mice that lack ovaries but is maintained at a constant level over
15 days. We concluded the reversible expression of Opa pro-
teins allows N. gonorrhoeae to evade or capitalize on hormon-
ally driven changes in the female reproductive tract. This find-
ing is the first experimental evidence from a highly
reproducible infection model that supports speculation based
FIG. 6. Fluctuations in vaginal C3 levels occur in uninfected mice, but C3 depletion does not abrogate the early selection for Opa variants.
(A) Concentration of C3 in vaginal washes from uninfected mice that were treated with 5-mg 17-estradiol slow-release pellets. A significantly
higher concentration of C3 was present in vaginal washes from days 7 and 8 (late phase) than in vaginal washes from days 3 to 5 (middle phase).
The results of two independent experiments in which 10 to 13 mice per day were used were combined. (B) Recovery of Opa variants in mice
treated with CVF to deplete C3 the day prior to inoculation with wild-type bacteria. Control mice were treated with PBS. Mice were challenged
with a predominantly Opa (80%) suspension of wild-type FA1090 gonococci, and the proportion of Opa variant colonies among colonies
isolated from vaginal mucus was determined on days 1 to 3 postinoculation. Selection for Opa expression, as defined as a 2-fold increase
compared to the inoculum (dotted line), occurred in both groups on day 1 or day 2 after bacterial challenge. The results of a single experiment
in which there were 3 or 4 mice per group are shown. (C) Effect of C3 depletion on the recovery of strain FA1090opaA-K. There was no difference
in the average numbers of Opa-deficient gonococci recovered from mice treated with CFU (solid line) and mice treated with PBS (dashed line)
on days 1 to 3 of infection. The results are the results of a single experiment performed with 7 mice per group, and similar results were obtained
in a second independent experiment. In all panels, the error bars indicate the standard errors of the means.
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on data for human cervical isolates (27) concerning the impor-
tance of opa gene phase variation during infection of women.
The results of experiments with Ov mice further illumi-
nated the basis for the decrease in the total number of gono-
cocci recovered that occurs during the middle phase of infec-
tion. We previously referred to the middle phase as the
culture-negative “window” (28) since often no gonococci are
recovered during this period. Here we showed that, in contrast
to what occurs in intact mice, there was no decrease in the total
number of gonococci during this time period when ovariecto-
mized mice were used. This observation suggests that hormon-
ally regulated host factors are responsible for the reduced
recovery of gonococci during this phase. Hormonally regulated
proteases could be expressed during this time period and ef-
fectively inhibit the growth of N. gonorrhoeae. A second hy-
pothesis is that unidentified effectors of the innate response
are responsible for the middle phase based on evidence that
receptors of the innate response, including Toll-like receptors,
are hormonally regulated (23, 47). This hypothesis is currently
our favored hypothesis based on a recent report from our
laboratory in collaboration with Robin Ingalls (Boston Univer-
sity Medical School) that signaling through Toll-like receptor 4
partially protects against N. gonorrhoeae (42). We also cannot
rule out the possibility that bacterial invasion may contribute to
the decrease in recoverable bacteria during the middle phase.
Tissue remodeling in preparation for implantation or for
sloughing when fertilization does not occur is orchestrated by
hormonally regulated proteases. Such proteases may directly
select for Opa variants or open an avenue for bacterial inva-
sion. Interestingly, Edwards recently reported that progester-
one increases gonococcal survival within epithelial cells (16), a
finding that is also consistent with the possibility that there are
times when gonococci may be less accessible for culture. Gono-
cocci are seen within vaginal and cervical tissue as early as 2
days postinfection in the mouse model (56), and whether bac-
terial invasion into tissue contributes to the cyclical recovery
pattern is not known. We attempted to use polarized HEC1B
cells to determine whether Opa proteins mediate invasion
across an epithelial cell layer in the absence of CEACAMs.
However, the HEC1B monolayers did not maintain their in-
tegrity for longer than 2 h, as measured by a horseradish
peroxidase leakage assay (62), which was an inadequate time
period to evaluate this possibility.
The decreased isolation of gonococci in intact mice that
characterizes the middle phase is consistent with the reported
association between the hormonal state and the culture rate
for women with gonorrhea. Women with gonorrhea are more
often culture positive in the proliferative stage of the menstrual
cycle and culture negative in the middle secretory phase (27,
32, 35, 38). In one study, 4 infected women with normal men-
strual cycles were not treated and hospitalized so the recovery
of N. gonorrhoeae could be followed over the course of a full
cycle. Positive cultures correlated strongly with the prolifera-
tive and ovulatory phases, and all 4 women had five or six
consecutive negative cultures during the secretory phase. Cul-
tures became positive again in the premenstrual phase or dur-
ing menses (35). The factors responsible for these culture-
FIG. 7. Opa gonococci are more susceptible to growth inhibition by serine proteases. A disk diffusion assay was used to measure the
sensitivities of recombinant and wild-type gonococci to trypsin or -chymotrypsin. Opa gonococci were more susceptible to growth inhibition
when they were exposed to serine proteases. (A) Zones of inhibition for the Opa-deficient mutant FA1090opaA-K and the complemented
OpaB-expressing mutant FA1090opaA-K(B) with different amounts of trypsin and -chymotrypsin. (B) Zones of inhibition for wild-type
Opa-negative gonococci and OpaA, OpaB, and OpaD variants with different amounts of -chymotrypsin. The average zones of inhibition (mm)
are indicated by the bars, and the error bars indicate standard errors. The disk diameter was 6 mm. The asterisks indicate statistical significance
(P  0.05).
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negative periods are not known but are likely related to the
reproductive cycle.
A second important finding was our demonstration that Opa
proteins promote persistence of N. gonorrhoeae in the lower
genital tract of female mice using genetically engineered bac-
terial strains. Mice infected with bacteria that constitutively
express OpaB were colonized longer than mice infected with
an isogenic Opa-deficient strain. The Opa strain also colo-
nized mice at higher levels early in infection and after the
period of reduced isolation during the middle phase. These
results confirm the prediction based on the results of our ex-
periments with wild-type N. gonorrhoeae that Opa protein ex-
pression is advantageous early and late during infection. Stud-
ies with wild-type gonococci also suggested that Opa variants
have an advantage during the middle phase. To our surprise,
however, the middle phase appeared to be Opa independent
when defined mutants were tested since the recovery of both
Opa-deficient and Opa-expressing strains was reduced on days
5 to 8 after inoculation. Because other workers have reported
an association between the isolation of opaque and transparent
human cervical isolates and different stages of the menstrual
cycle (27), we hypothesized that the forces selecting for the
Opa phenotype during the middle phase may be subtle and
detectable only when the relative numbers of Opa and Opa
gonococci in the same mouse are compared.
The final outcome of this work was the generation of data
that do not support two well-characterized Opa protein func-
tions as the basis for the selection for Opa variants during
murine infection. Opa proteins mediate adherence and inva-
sion of cultured human cells via interactions with different
receptors, and these interactions have been fully investigated
at the molecular level (4, 6, 45, 61). Here, however, we found
no difference in the capacities of Opa and Opa gonococci to
adhere to or invade cultured murine cells and thus have no
evidence that Opa proteins act as colonization factors in the
mouse model. We cannot rule out the possibility that there is
an Opa-specific colonization receptor in the murine genital tract,
which is not expressed by the mouse cell lines used but selects for
Opa expression in vivo. The best-characterized Opa receptors are
the human CEACAMs. Mice express only CEACAM1, which
differs from human CEACAM1 in several amino acids shown to
be critical for Opa-mediated binding (60, 61). It is therefore
unlikely that Opa-mediated colonization via murine CEACAMs
selects for Opa variants during murine infection. Some Opa
proteins mediate uptake by epithelial cells via binding to hep-
arin sulfate proteoglycans (HSPG) (40), and HSPG is present
on genital tract tissues (22). However, the only Opa protein of
strain FA1090 that binds HSPG is OpaI; OpaB, which was the
main Opa phenotype selected in our study, binds human
CEACAMs (17). We also found that although OpaI variants
are selected in mice following inoculation with a suspension
containing mostly Opa variants (52), inoculation of mice with
a suspension containing similar numbers of OpaI and OpaB
variants did not result in preferential selection for OpaI during
infection (J. G. Cole and A. E. Jerse, unpublished observa-
tion). Therefore, the importance of Opa protein-HSPG inter-
actions during murine infection is questionable.
Whether Opa-CEACAM interactions are responsible for or
contribute to the selection for Opa gonococci in the human
cervix or the male urethra (27, 29, 58) is also not clear. The
tissue distribution of the major class of Opa protein adherence
receptors, the human CEACAMs, does not correlate with the
predominant sites of gonococcal infection in humans. For ex-
ample, limited or no CEACAM expression was detected on
primary male urethral epithelial cells (20) and some normal
cervical and fallopian tube cells (59).
A second hypothesis was that host complement is responsi-
ble for early selection for Opa variants early and late during
infection based on the known hormonal regulation of comple-
ment in female mice and women of reproductive age (21, 36)
and the demonstration of Opa-mediated serum resistance in
another strain. Serum resistance is a complicated phenotype in
N. gonorrhoeae due the existence of several mechanisms that
are not expressed by all strains. We found that in the absence
of porin-mediated resistance in strain FA1090, a highly serum-
resistant strain, some Opa proteins, either alone or in conjunc-
tion with other Opa proteins, conferred increased resistance to
concentrations of NHS that reasonably mimic the concentra-
tion of complement at mucosal surfaces. Whether the higher
50% bactericidal titers that we observed are biologically sig-
nificant is not known; however, at one NHS concentration
tested, 3%, the level of survival for OpaB and OpaE/K vari-
ants, which showed cyclical recovery here and in our previous
studies (52), was not significantly greater than that for Opa
bacteria. In studies with strain MS11, expression of certain
phase-variable species of lipooligosaccharide (LOS) was phe-
notypically dominant over expression of Opa proteins for me-
diating serum resistance (5). We saw no difference in the LOS
species produced by the Opa variants tested here or the Opa-
deficient and constitutive OpaB-expressing strains (data not
shown), however, and thus our results are unlikely to be con-
founded by differences in LOS phenotype. We also examined
whether complement selects for Opa gonococci early in in-
fection using C3-depleted mice. Depletion of C3 to a level that
was 90 to 95% of the level found in untreated mice did not
abrogate the early selection for Opa gonococci. We con-
cluded that while complement may contribute to the selection
of Opa variants during murine infection, it does not mediate
the early selection of Opa variants. The use of complement-
deficient mice would be a more stringent test of our hypothesis;
however, C3- and C5-deficient mice are available only in the
C57/BL6 background, and we have not characterized Opa pro-
tein expression in C57/BL6 mice.
In conclusion, the host factors responsible for Opa selection
during murine infection remain elusive. The female genital
tract is a dynamic environment in which multiple effectors may
play a selective role. Hormonally regulated changes in innate
receptors (23, 47), the levels of antimicrobial peptides (34),
lactoferrin (9), pH, the viscosity of mucus, and the number and
composition of commensal organisms (8) also occur. One or
more of these factors may differentially select for Opa or
Opa gonococci, or a combination of factors, such as the
reported synergy between lactoferrin, lysozyme, and serine leu-
kocyte protease inhibitor (SLPI) against E. coli (53), may be
required. Continued investigation of the basis of the cyclical
recovery pattern that we describe here should further elucidate
how N. gonorrhoeae, a well-adapted pathogen, has evolved to
evade or capitalize on hormonally driven factors within the
female genital tract.
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